Filing Flows › Strata Critical Medical (SRTA) › Q3 2025
Strata Critical Medical (SRTA) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 10, 2025
Strata Critical Medical (SRTA) reported revenue of $49.3M for the third quarter 2025 (Q3 2025), +37% from a year earlier and -30% from the quarter before. Operating margin was -11.4%, net earnings $57.4M (116.5% of revenue).
Strata Critical Medical, Q3 2025: revenue $49.3M (+37% year over year), operating margin -11.4%, net earnings $57.4M, operating cash flow −$37.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $49.3M | -30% | +37% |
| Operating profit | −$5.6M | — | — |
| Net earnings | $57.4M | — | — |
| Operating cash flow | −$37.3M | — | — |
What changed
Revenue was $49.3M in Q3 2025, up 37% year over year and down 30% from the previous quarter.
Operating costs exceeded revenue by $5.6M, an operating margin of -11.4%. Total costs grew 27% against revenue growth of 37%. The fastest-growing cost line was Sales & marketing (+54%). Net earnings were $57.4M. The effective tax rate was 0.0%. Non-operating items added $63.0M, 110% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$37.3M. Non-cash charges added back $1.7M of depreciation and amortization and $1.7M of share-based compensation. Working capital and other items used $98.1M. Capital expenditures of $2.9M exceeded it, leaving free cash flow of −$40.2M.
Questions
What was Strata Critical Medical's revenue in the third quarter 2025?
Strata Critical Medical (SRTA) reported revenue of $49.3M for the third quarter 2025 (Q3 2025), +37% from a year earlier and -30% from the quarter before.
Was Strata Critical Medical profitable in the third quarter 2025?
Operating loss was $5.6M (-11.4% of revenue) and net earnings $57.4M.